Cronos (CRON) Capital Expenditures (2019 - 2026)
Cronos (CRON) posted quarterly Capital Expenditures of $1.9 million for Q1 2026, down 87.71% year-over-year from $15.3 million in Q1 2025, and down 12.34% quarter-over-quarter from $2.1 million in Q4 2025.
Cronos (CRON) Capital Expenditures (2019 - 2026) Analysis & Trends
Cronos' Capital Expenditures history runs 8 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 87.71% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $12.3 million (down 52.46% YoY), while the FY2025 annual figure was $25.7 million, up 107.21% from the prior year.
- Capital Expenditures for Q1 2026 stood at $1.9 million, down from $2.1 million in the prior quarter.
- The five-year high for Capital Expenditures was $15.3 million in Q1 2025, with the low at $67000.0 in Q3 2023.
- The 5-year median for Capital Expenditures is $1.5 million (2022), against an average of $2.7 million.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures plunged 94.23% in 2022, then soared 9474.63% in 2024.
- Cronos' Capital Expenditures stood at $364000.0 in 2022, then soared by 234.62% to $1.2 million in 2023, then soared by 190.89% to $3.5 million in 2024, then slumped by 39.63% to $2.1 million in 2025, then declined by 12.34% to $1.9 million in 2026.
- Business Quant data shows CRON's Capital Expenditures at $1.9 million in Q1 2026, $2.1 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cronos | 1.20 Bn | 407.87 Mn | 28.45 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Jun 30, 2026 | 1.74 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 3.84 Mn |
| Mar 31, 2025 | 15.26 Mn |
| Mar 31, 2025 | 15.26 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | 729,000.00 |
| Jun 30, 2024 | 729,000.00 |
| Mar 31, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.72 Mn |